XML 69 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Options Outstanding and Exercised Under Stock Incentive Plans
The following is a summary of stock options outstanding and exercised under prior and existing stock incentive plans of the Company:
Year Ended December 31Stock
 Options/Shares
Weighted- Average Exercise PriceWeighted-Average Remaining Contractual TermAggregate Intrinsic Value (in millions)
 
2023
Number outstanding at beginning of period3,253,090 $44.42 
Exercised(399,329)38.15 
Cancelled(a)
(15,476)47.88 
Number outstanding at end of period(b)
2,838,285 $45.28 2.0$— 
Exercisable at end of period2,838,285 $45.28 2.0$— 
2022
Number outstanding at beginning of period3,890,131 $42.58 
Exercised(624,729)32.87 
Cancelled(a)
(12,312)50.97 
Number outstanding at end of period(b)
3,253,090 $44.42 2.7$— 
Exercisable at end of period3,253,090 $44.42 2.7$— 
2021
Number outstanding at beginning of period5,180,391 $40.38 
Exercised(1,281,646)33.66 
Cancelled(a)
(8,614)48.20 
Number outstanding at end of period(b)
3,890,131 $42.58 3.3$53 
Exercisable at end of period3,890,131 $42.58 3.3$53 
Note: The Company did not grant any stock option awards during 2023, 2022, and 2021.
(a)Options cancelled include both non-vested (i.e., forfeitures) and vested options.
(b)Outstanding options include stock-based awards that may be forfeited in future periods. The impact of the estimated forfeitures is reflected in compensation expense.
Stock Option Activity
The following summarizes certain stock option activity of the Company:
Year Ended December 31 (Dollars in Millions)202320222021
Fair value of options vested$— $— $
Intrinsic value of options exercised15 27 
Cash received from options exercised15 21 43 
Tax benefit realized from options exercised
Stock Options Outstanding Additional Information
Additional information regarding stock options outstanding as of December 31, 2023, is as follows:
 Outstanding OptionsExercisable Options
Range of Exercise PricesSharesWeighted- Average Remaining Contractual Life (Years)Weighted- Average Exercise PriceSharesWeighted- Average Exercise Price
$35.01—$40.00
1,008,0462.1$39.49 1,008,046$39.49 
$40.01—$45.00
988,8800.842.95 988,88042.95 
$45.01—$50.00
— 
$50.01—$55.01
841,3593.154.96 841,35954.96 
 2,838,2852.0$45.28 2,838,285$45.28 
Summary of Restricted Shares of Stock and Unit Awards
A summary of the status of the Company’s restricted shares of stock and unit awards is presented below:
 202320222021
Year Ended December 31SharesWeighted-Average Grant-Date Fair ValueSharesWeighted-Average Grant-Date Fair ValueSharesWeighted-Average Grant-Date Fair Value
Outstanding at beginning of period6,880,826 $52.59 6,812,753 $51.04 6,343,313 $51.38 
Granted5,565,634 45.87 4,109,793 55.62 4,512,995 52.54 
Vested(3,872,874)52.05 (3,690,666)52.88 (3,793,978)53.27 
Cancelled(257,015)50.00 (351,054)54.95 (249,577)52.83 
Outstanding at end of period8,316,571 $48.42 6,880,826 $52.59 6,812,753 $51.04